• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名青少年截肢患者的万古霉素和庆大霉素药代动力学改变

Vancomycin and gentamicin pharmacokinetic alterations in an adolescent amputee.

作者信息

Nichols Kristen R, Edison Kari M, Rosenbaum Michelle D, Knoderer Chad A

机构信息

Department of Pharmacy Practice, College of Pharmacy and Health Sciences, Butler University, Indianapolis, Indiana ; Department of Pharmacy, Riley Hospital for Children, Indiana University Health, Indianapolis, Indiana ; Department of Pediatrics, Ryan White Center for Pediatric Infectious Disease, Indiana University School of Medicine, Indianapolis, Indiana.

出版信息

J Pediatr Pharmacol Ther. 2013 Jan;18(1):63-6. doi: 10.5863/1551-6776-18.1.63.

DOI:10.5863/1551-6776-18.1.63
PMID:23616737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3626068/
Abstract

A 14-year-old male with bilateral above-the-knee amputations presented to our hospital for treatment of a skin and soft-tissue infection. We report the experience of vancomycin and gentamicin therapy in this patient. Because these medications require weight-based dosages and pharmacokinetic monitoring of serum levels, it was necessary to obtain peak and trough levels of the two drugs in order to determine the pharmacokinetic differences in this patient compared to those in an adolescent male without amputations. To our knowledge, this is the first report describing pharmacokinetic differences in an adolescent amputee.

摘要

一名14岁双侧膝上截肢男性因皮肤和软组织感染前来我院治疗。我们报告了该患者使用万古霉素和庆大霉素治疗的经验。由于这些药物需要根据体重给药并对血清水平进行药代动力学监测,因此有必要测定这两种药物的峰浓度和谷浓度,以确定该患者与未截肢青少年男性相比的药代动力学差异。据我们所知,这是第一份描述青少年截肢者药代动力学差异的报告。

相似文献

1
Vancomycin and gentamicin pharmacokinetic alterations in an adolescent amputee.一名青少年截肢患者的万古霉素和庆大霉素药代动力学改变
J Pediatr Pharmacol Ther. 2013 Jan;18(1):63-6. doi: 10.5863/1551-6776-18.1.63.
2
Population pharmacokinetic modelling of gentamicin and vancomycin in patients with unstable renal function following cardiothoracic surgery.心脏胸外科手术后肾功能不稳定患者庆大霉素和万古霉素的群体药代动力学建模
Br J Clin Pharmacol. 2006 Feb;61(2):164-76. doi: 10.1111/j.1365-2125.2005.02547.x.
3
Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.评估万古霉素在儿科患者中的给药剂量和随后的血清浓度。
Ann Pharmacother. 2011 May;45(5):582-9. doi: 10.1345/aph.1P588. Epub 2011 Apr 26.
4
External Validation of Model-Based Dosing Guidelines for Vancomycin, Gentamicin, and Tobramycin in Critically Ill Neonates and Children: A Pragmatic Two-Center Study.基于模型的万古霉素、庆大霉素和妥布霉素在危重新生儿和儿童中的剂量指南的外部验证:一项实用的两中心研究。
Paediatr Drugs. 2020 Aug;22(4):433-444. doi: 10.1007/s40272-020-00400-8.
5
Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.新生儿和婴儿的万古霉素药代动力学:一项回顾性评估。
Ann Pharmacother. 1993 Apr;27(4):490-6. doi: 10.1177/106002809302700417.
6
Altered gentamicin pharmacokinetics during the perioperative period.
Clin Pharm. 1985 Mar-Apr;4(2):182-5.
7
Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study.庆大霉素在早产儿和足月儿中的发育药代动力学:一项前瞻性研究的群体建模
Clin Pharmacokinet. 2009;48(4):253-63. doi: 10.2165/00003088-200948040-00003.
8
Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia.老年医院获得性肺炎患者中万古霉素临床疗效与新的药代动力学参数谷浓度下面积(AUTL)的相关性。
J Clin Pharm Ther. 2016 Aug;41(4):399-402. doi: 10.1111/jcpt.12399. Epub 2016 May 4.
9
Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.万古霉素在疑似或确诊金黄色葡萄球菌感染的极度肥胖患者中的药代动力学。
Pharmacotherapy. 2015 Feb;35(2):127-39. doi: 10.1002/phar.1531. Epub 2015 Feb 3.
10
Vancomycin Pharmacokinetics in Obese Patients with Sepsis or Septic Shock.肥胖脓毒症或感染性休克患者的万古霉素药代动力学。
Pharmacotherapy. 2020 Mar;40(3):211-220. doi: 10.1002/phar.2367. Epub 2020 Feb 5.

本文引用的文献

1
Pharmacokinetics and drug dosing in obese children.肥胖儿童的药代动力学与药物剂量
J Pediatr Pharmacol Ther. 2010 Apr;15(2):94-109.
2
Vancomycin dosing in obese pediatric patients.肥胖儿科患者的万古霉素给药剂量
Clin Pediatr (Phila). 2011 May;50(5):442-6. doi: 10.1177/0009922810393500. Epub 2011 Jan 31.
3
Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.成人患者万古霉素的治疗监测:美国卫生系统药师协会、美国传染病学会和传染病药师协会的共识综述
Am J Health Syst Pharm. 2009 Jan 1;66(1):82-98. doi: 10.2146/ajhp080434.
4
Method for estimating body weight in persons with lower-limb amputation and its implication for their nutritional assessment.
Am J Clin Nutr. 2004 Oct;80(4):868-75. doi: 10.1093/ajcn/80.4.868.
5
Developmental pharmacology--drug disposition, action, and therapy in infants and children.发育药理学——婴幼儿的药物处置、作用及治疗
N Engl J Med. 2003 Sep 18;349(12):1157-67. doi: 10.1056/NEJMra035092.
6
Vancomycin pharmacokinetics and Bayesian estimation in pediatric patients.儿科患者中万古霉素的药代动力学及贝叶斯估计
Ther Drug Monit. 2000 Oct;22(5):522-31. doi: 10.1097/00007691-200010000-00004.
7
A population pharmacokinetic model for vancomycin in pediatric patients and its predictive value in a naive population.儿童患者万古霉素群体药代动力学模型及其在初治人群中的预测价值。
Antimicrob Agents Chemother. 2000 Feb;44(2):278-82. doi: 10.1128/AAC.44.2.278-282.2000.
8
Pharmacokinetics and administration regimens of vancomycin in neonates, infants and children.万古霉素在新生儿、婴儿和儿童中的药代动力学及给药方案。
Clin Pharmacokinet. 1997 Jul;33(1):32-51. doi: 10.2165/00003088-199733010-00004.
9
Synergy of penicillin and decreasing concentration of aminoglycosides against enterococci from patients with infective endocarditis.青霉素与降低浓度的氨基糖苷类药物对感染性心内膜炎患者肠球菌的协同作用。
Antimicrob Agents Chemother. 1980 Dec;18(6):944-7. doi: 10.1128/AAC.18.6.944.
10
Two methods for estimating body surface area in adult amputees.两种用于估计成年截肢者体表面积的方法。
Am J Hosp Pharm. 1984 Dec;41(12):2650-5.